Don't forget that they have significant Depreciation/ Amortisation costs (3.5m in 1/2 Year Dec, 5.6m LY). It would still be a net accounting loss for the year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025